| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |